2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum

C134H106N26O12Pt6 — CID 159423740

About 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum

2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum (PubChem CID 159423740) has the molecular formula C134H106N26O12Pt6 and a molecular weight of 3442.96 g/mol. Its IUPAC name is 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum.

Molecular Properties

• Compound Name: 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum
• PubChem CID: 159423740
• Molecular Formula: C134H106N26O12Pt6
• Molecular Weight: 3442.96 g/mol
• Exact Mass: 3440.64
• IUPAC Name: 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum
• SMILES: CC(C)(C)c1nc(-c2ccccc2O)nc2c1ccc1c(C(C)(C)C)nc(-c3ccccc3O)nc12.CC1(C)N=C(C2=NC(C)(C)C(c3ccccc3O)=N2)N=C1c1ccccc1O.Oc1cccc2ccn3cc(-c4cn5ccc6cccc(O)c6c5n4)nc3c12.Oc1ccccc1-c1cnc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1cncc(-c2cncc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1ncnc(-c2ncnc(-c3ccccc3O)n2)n1.[Pt].[Pt].[Pt].[Pt].[Pt].[Pt]
• InChI: InChI=1S/C30H30N4O2.2C22H14N4O2.C22H22N4O2.C20H14N4O2.C18H12N6O2.6Pt/c1-29(2,3)25-19-15-16-20-24(23(19)31-27(33-25)17-11-7-9-13-21(17)35)32-28(34-26(20)30(4,5)6)18-12-8-10-14-22(18)36;27-17-5-1-3-13-7-9-25-11-15(23-21(25)19(13)17)16-12-26-10-8-14-4-2-6-18(28)20(14)22(26)24-16;27-19-7-3-1-5-13(19)17-11-23-15-9-10-16-22(21(15)25-17)26-18(12-24-16)14-6-2-4-8-20(14)28;1-21(2)17(13-9-5-7-11-15(13)27)23-19(25-21)20-24-18(22(3,4)26-20)14-10-6-8-12-16(14)28;25-19-7-3-1-5-13(19)15-9-21-11-17(23-15)18-12-22-10-16(24-18)14-6-2-4-8-20(14)26;25-13-7-3-1-5-11(13)15-19-9-21-17(23-15)18-22-10-20-16(24-18)12-6-2-4-8-14(12)26;;;;;;/h7-16,35-36H,1-6H3;2*1-12,27-28H;5-12,27-28H,1-4H3;1-12,25-26H;1-10,25-26H
• InChIKey: LHDIGFHSYDEGFO-UHFFFAOYSA-N
• XLogP: 25.49
• TPSA: 558.82 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 38
• Rotatable Bonds: 14
• Heavy Atoms: 178
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3442.96
LogP ≤ 5	25.49
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	38

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

The IUPAC name of 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum (CID 159423740) is 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum.

What is the SMILES notation for 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

The canonical SMILES for 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum is CC(C)(C)c1nc(-c2ccccc2O)nc2c1ccc1c(C(C)(C)C)nc(-c3ccccc3O)nc12.CC1(C)N=C(C2=NC(C)(C)C(c3ccccc3O)=N2)N=C1c1ccccc1O.Oc1cccc2ccn3cc(-c4cn5ccc6cccc(O)c6c5n4)nc3c12.Oc1ccccc1-c1cnc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1cncc(-c2cncc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1ncnc(-c2ncnc(-c3ccccc3O)n2)n1.[Pt].[Pt].[Pt].[Pt].[Pt].[Pt].

What is the InChIKey of 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

The InChIKey is LHDIGFHSYDEGFO-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H30N4O2.2C22H14N4O2.C22H22N4O2.C20H14N4O2.C18H12N6O2.6Pt/c1-29(2,3)25-19-15-16-20-24(23(19)31-27(33-25)17-11-7-9-13-21(17)35)32-28(34-26(20)30(4,5)6)18-12-8-10-14-22(18)36;27-17-5-1-3-13-7-9-25-11-15(23-21(25)19(13)17)16-12-26-10-8-14-4-2-6-18(28)20(14)22(26)24-16;27-19-7-3-1-5-13(19)17-11-23-15-9-10-16-22(21(15)25-17)26-18(12-24-16)14-6-2-4-8-20(14)28;1-21(2)17(13-9-5-7-11-15(13)27)23-19(25-21)20-24-18(22(3,4)26-20)14-10-6-8-12-16(14)28;25-19-7-3-1-5-13(19)15-9-21-11-17(23-15)18-12-22-10-16(24-18)14-6-2-4-8-20(14)26;25-13-7-3-1-5-11(13)15-19-9-21-17(23-15)18-22-10-20-16(24-18)12-6-2-4-8-14(12)26;;;;;;/h7-16,35-36H,1-6H3;2*1-12,27-28H;5-12,27-28H,1-4H3;1-12,25-26H;1-10,25-26H;;;;;;.

What are the key properties of 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum has a molecular weight of 3442.96 g/mol, XLogP of 25.49, 14 rotatable bonds, 12 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[4,7-ditert-butyl-2-(2-hydroxyphenyl)pyrimido[5,4-h]quinazolin-9-yl]phenol;2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum is sourced from PubChem (CID 159423740), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).